By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 113.20 |
Change Today | $ -1.32 |
% Change | -1.15 % |
52 Week High | $117.41 |
52 Week Low | $72.73 |
Volume | 1,710,567 |
Shares Issued | 1,246.00m |
Market Cap | $141,041m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 10 |
Neutral | 7 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
12:38 | 100 @ $113.20 |
12:38 | 100 @ $113.20 |
12:38 | 100 @ $113.20 |
12:38 | 274 @ $113.19 |
12:38 | 126 @ $113.19 |
You are here: research